Why Brainchip, Core Lithium, Deterra Royalties, and Mesoblast shares are falling

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a solid gain. At the time of writing, the benchmark index is up 0.9% to 7,343.7 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are falling:

Brainchip Holdings Ltd (ASX: BRN)

The Brainchip share price is down a further 1.5% to 66 cents. This semiconductor company’s shares have come under pressure this week after it raised capital again. Investors appear concerned that this could mean the company’s latest quarterly sales performance underwhelmed and it needed a cash injection.

Core Lithium Ltd (ASX: CXO)

The Core Lithium share price is down 3% to $1.15. This may have been driven by a bearish broker note out of Goldman Sachs this morning. According to the note, the broker has reiterated its sell rating and 95 cents price target on this lithium developer’s shares. Goldman believes Core Lithium’s shares are overvalued at the current level.

Deterra Royalties Ltd (ASX: DRR)

The Deterra Royalties share price is down 2.5% to $4.68. This may also have been driven by a broker note out of Goldman Sachs. This morning, the broker downgraded the mining royalties company’s shares to a neutral rating with a $4.50 price target. Goldman made the move largely on valuation grounds after a strong gain since October.

Mesoblast Ltd (ASX: MSB)

The Mesoblast share price is down 2.5% to 93.5 cents. This is despite there being no news out of the biotech company. However, with its shares up strongly since the start of the year, some profit taking could be happening. The Mesoblast share price remains up 7% year to date.

The post Why Brainchip, Core Lithium, Deterra Royalties, and Mesoblast shares are falling appeared first on The Motley Fool Australia.

Turn the market pullback to your advantage today

The recent market pullback in stocks has been eye watering…

But there is a silver lining because, historically, some millionaires are made in bear markets.

And when investors can find world-class stocks at severe discounts you have to wonder…

Have you got these four ‘pullback stocks’ in your portfolio?

See The 4 Stocks
*Returns as of January 5 2023

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/UhFfGeP

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *